CytRx

CytRx

CytRx Corp. (NASDAQCYTR) is a biopharmaceutical research and development oncology company in Los Angeles, California.

The CytRx oncology pipeline includes three programs in clinical development: bafetinib, tamibarotene and INNO-206. The company is evaluating bafetinib in the ENABLE Phase 2 clinical trial in high-risk B-cell chronic lymphocytic leukemia (B-CLL), a pharmacokinetic clinical trial in brain cancer and the PROACT Phase 2 clinical trial in advanced prostate cancer. With its tumor-targeting pro-drug candidate INNO-206, CytRx is conducting a safety trial with plans to initiate Phase 2 proof-of-concept clinical trials as a treatment for soft tissue sarcomas and pancreatic cancer. CytRx's pipeline also includes tamibarotene, which it is testing in patients with non-small-cell lung cancer and which is in a registration clinical trial as a treatment for acute promyelocytic leukemia (APL).

Arimoclomol (INN, originally codenamed BRX-220) is an experimental drug developed by CytRx. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease.

See also http://en.wikipedia.org/wiki/Steven_Arthur_Kriegsman

==External links==

Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать курсовую

Look at other dictionaries:

  • CYTR — Cytrx Corporation (Business » NASDAQ Symbols) …   Abbreviations dictionary

  • Arimoclomol — is an experimental drug compound developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. The orally administered drug is intended to treat amyotrophic lateral sclerosis (ALS). Mechanism of Action The small… …   Wikipedia

  • Amyotrophic lateral sclerosis — This article is about progressive Motor Neuron Disease (MND) affecting both the upper motor neurons and lower motor neurons. For MND affecting either but not necessarily both, see Motor neurone disease. ALS redirects here. For other uses, see ALS …   Wikipedia

  • Bcr-Abl tyrosine-kinase inhibitor — Bcr Abl tyrosine kinase inhibitors (TKI) are the first line therapy for most patients with chronic myelogenous leukemia (CML). In more than 90% cases CML is caused by chromosomal abnormality resulting in the formation of a so called Philadelphia… …   Wikipedia

  • Bafetinib — Strukturformel Allgemeines Freiname Bafetinib Andere Namen …   Deutsch Wikipedia

  • Johnson & Johnson — Not to be confused with S. C. Johnson Son. Johnson Johnson Type Public Traded as NYSE:  …   Wikipedia

  • Schering-Plough — Corporation Type Subsidiary Industry Pharmaceuticals Fate Merged with Merck Co …   Wikipedia

  • Covance — Type Public (NYSE: CVD) Industry Contract Research Organizations Pharmaceutical Founded 1997 …   Wikipedia

  • Anti-obesity drug — Anti obesity drugs or weight loss drugs refer to all pharmacological agents that reduce or control weight. These drugs alter one of the fundamental processes of the human body, weight regulation, by either altering appetite or metabolism.The main …   Wikipedia

  • McKesson Corporation — Type Public Traded as NYSE: MCK NASDAQ 100 Component …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”